Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2012, Article ID 547840, 9 pages
http://dx.doi.org/10.1155/2012/547840
Review Article

Tutorial Review for Understanding of Cholangiopathy

Department of Human Pathology, Kanazawa University Graduate School of Medical Science, Kanazawa 920-8640, Japan

Received 23 March 2011; Accepted 23 June 2011

Academic Editor: A. J. Demetris

Copyright © 2012 Yasuni Nakanuma. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Nakanuma, Y. Zen, and B. C. Portman, “Diseases of the bile ducts,” in MacSween’s Pathology of the Liver, A. D. Burt, B. C. Portman, and L. D. Ferrell, Eds., Churchill Levingstone, New York, NY, USA, 6th edition, 2011. View at Google Scholar
  2. K. Harada, S. Ozaki, M. E. Gershwin, and Y. Nakanuma, “Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis,” Hepatology, vol. 26, no. 6, pp. 1399–1405, 1997. View at Google Scholar · View at Scopus
  3. Y. Zen, T. Fujii, K. Harada et al., “Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis,” Hepatology, vol. 45, no. 6, pp. 1538–1546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. C. L. Jay, V. Lyuksemburg, D. P. Ladner et al., “Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis,” Annals of Surgery, vol. 253, no. 2, pp. 259–264, 2011. View at Publisher · View at Google Scholar
  5. Y. Nakanuma, M. Hoso, T. Sanzen, and M. Sasaki, “Microstructure and development of the normal and pathologic biliary tract in humans, including blood supply,” Microscopy Research and Technique, vol. 38, no. 6, pp. 552–570, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Turner, O. Lozoya, Y. Wang et al., “Human hepatic stem cell and maturational liver lineage biology,” Hepatology, vol. 53, no. 3, pp. 1035–1045, 2011. View at Publisher · View at Google Scholar
  7. T. Terada, Y. Nakanuma, and G. Ohta, “Glandular elements around the intrahepatic bile ducts in man; their morphology and distribution in normal livers,” Liver, vol. 7, no. 1, pp. 1–8, 1987. View at Google Scholar · View at Scopus
  8. V. Cardinale, Y. Wang, G. Carpino, D. Alvaro, L. Reid, and E. Gaudio, “Multipotent stem cells in the biliary tree,” Italian Journal of Anatomy and Embryology, vol. 115, no. 1-2, pp. 85–90, 2010. View at Google Scholar
  9. M. Sasaki, H. Ikeda, and Y. Nakanuma, “Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance,” Progress in Histochemistry and Cytochemistry, vol. 42, no. 2, pp. 61–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Nakanuma and M. Sasaki, “Expression of blood group-related antigens in the intrahepatic biliary tree and hepatocytes in normal livers and various hepatobiliary diseases,” Hepatology, vol. 10, no. 2, pp. 174–178, 1989. View at Google Scholar · View at Scopus
  11. P. Deltenre and D. C. Valla, “Ischemic cholangiopathy,” Seminars in Liver Disease, vol. 28, no. 3, pp. 235–246, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Kobayashi, Y. Nakanuma, and O. Matsui, “Intrahepatic peribiliary vascular plexus in various hepatobiliary diseases: a histological survey,” Human Pathology, vol. 25, no. 9, pp. 940–946, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Koda, K. Harada, K. Tsuneyama et al., “Evidence of the participation of peribiliary mast cells in regulation of the peribiliary vascular plexus along intrahepatic biliary tree,” Laboratory Investigation, vol. 80, no. 7, pp. 1007–1017, 2000. View at Google Scholar · View at Scopus
  14. K. N. Lazaridis and N. F. LaRusso, “Bile formation: do not ignore the role of plasma membrane-cytoskeleton linking proteins,” Hepatology, vol. 37, pp. 218–220, 2003. View at Google Scholar
  15. K. Harada and Y. Nakanuma, “Intrahepatic bile duct loss in immune-mediated ductopenic biliary diseases with an emphasis on biliary epithelial apoptosis,” Minerva Gastroenterologica e Dietologica, vol. 49, no. 1, pp. 41–51, 2003. View at Google Scholar · View at Scopus
  16. K. Hiramatsu, K. Harada, K. Tsuneyama et al., “Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis,” Journal of Hepatology, vol. 33, no. 1, pp. 9–18, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Isse, K. Harada, Y. Sato, and Y. Nakanuma, “Characterization of biliary intra-epithelial lymphocytes at different anatomical levels of intrahepatic bile ducts under normal and pathological conditions: numbers of CD4+CD28- intra-epithelial lymphocytes are increased in primary biliary cirrhosis,” Pathology International, vol. 56, no. 1, pp. 17–24, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Matsumoto, H. Matsumori, Y. Hosokawa et al., “A light and electron microscopic study of the regenerative epithelium in the intrahepatic bile duct. Experimental study of local direct instillation of paraquat into the intrahepatic bile ducts of rats,” Acta Pathologica Japonica, vol. 36, no. 8, pp. 1163–1180, 1986. View at Google Scholar
  19. M. Sasaki, M. Miyakoshi, Y. Sato, and Y. Nakanuma, “Modulation of the microenvironment by senescent biliary epithelial cells may be involved in the pathogenesis of primary biliary cirrhosis,” Journal of Hepatology, vol. 53, no. 2, pp. 318–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Krizhanovsky, M. Yon, R. A. Dickins et al., “Senescence of activated stellate cells limits liver fibrosis,” Cell, vol. 134, no. 4, pp. 657–667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Sasaki, H. Ikeda, J. Yamaguchi, S. Nakada, and Y. Nakanuma, “Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence,” Hepatology, vol. 48, no. 1, pp. 186–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Sasaki, H. Ikeda, Y. Sato, and Y. Nakanuma, “Decreased expression of Bmi1 is closely associated with cellular senescence in small bile ducts in primary biliary cirrhosis,” American Journal of Pathology, vol. 169, no. 3, pp. 831–845, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. K. Isse, K. Harada, Y. Zen et al., “Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts,” Hepatology, vol. 41, no. 3, pp. 506–516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Malhi and G. J. Gores, “Cholangiocarcinoma: modern advances in understanding a deadly old disease,” Journal of Hepatology, vol. 45, no. 6, pp. 856–867, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. T. A. Roskams, N. D. Theise, C. Balabaud et al., “Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers,” Hepatology, vol. 39, no. 6, pp. 1739–1745, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. Y. Nakanuma, M. P. Curabo, S. Franceschi et al., “Intrahepatic cholangiocarcinoma,” in WHO Classification of Tumours of the Digestive System, F. T. Bosman, F. Carneiro, R. H. Hruban, and N. D. Theise, Eds., World Health Organization of Tumours, pp. 217–224, IARC Press, Lyon, France, 4th edition, 2004. View at Google Scholar
  27. J. Ludwig, A. J. Czaja, E. R. Dickson, N. F. LaRusso, and R. H. Wiesner, “Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology,” Liver, vol. 4, no. 2, pp. 105–116, 1984. View at Google Scholar · View at Scopus
  28. Y. Nakanuma, K. Harada, Y. Sato, and H. Ikeda, “Recent progress in the etiopathogenesis of pediatric biliary disease, particularly Caroli's disease with congenital hepatic fibrosis and biliary atresia,” Histology and Histopathology, vol. 25, no. 2, pp. 223–235, 2010. View at Google Scholar · View at Scopus
  29. K. Harada, Y. Sato, H. Ikeda et al., “Epithelial-mesenchymal transition induced by biliary innate immunity contributes to the sclerosing cholangiopathy of biliary atresia,” Journal of Pathology, vol. 217, no. 5, pp. 654–664, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Nakanuma, M. Sasaki, A. Ishikawa, W. Tsui, T. C. Chen, and S. F. Huang, “Biliary papillary neoplasm of the liver,” Histology and Histopathology, vol. 17, no. 3, pp. 851–861, 2002. View at Google Scholar · View at Scopus
  31. Y. Nakanuma, T. Terada, and G. Ohta, “Caroli's disease in congenital hepatic fibrosis and infantile polycystic disease,” Liver, vol. 2, no. 4, pp. 346–354, 1982. View at Google Scholar · View at Scopus
  32. G. M. Hirschfield, E. J. Heathcote, and M. E. Gershwin, “Pathogenesis of cholestatic liver disease and therapeutic approaches,” Gastroenterology, vol. 139, no. 5, pp. 1481–1496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. K. Harada and Y. Nakanuma, “Biliary innate immunity in the pathogenesis of biliary diseases,” Inflammation and Allergy, vol. 9, no. 2, pp. 83–90, 2010. View at Google Scholar · View at Scopus
  34. W. M.-S. Tsui, Y.-K. Chan, C.-T. Wong, Y.-F. Lo, Y.-W. Yeung, and Y.-W. Lee, “Hepatolithiasis and the syndrome of recurrent pyogenic cholangitis: clinical, radiologic, and pathologic features,” Seminars in Liver Disease, vol. 31, no. 1, pp. 33–48, 2011. View at Publisher · View at Google Scholar
  35. Y. Zen, T. Fujii, K. Itatsu et al., “Biliary papillary tumors share pathological features with intraductal papillary mucinous neoplasm of the pancreas,” Hepatology, vol. 44, no. 5, pp. 1333–1343, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. B. C. Portman and E. A. Roberts, “Developmental abnormalities and liver disease in childhood,” in MacSween’s Pathology of the Liver, A. D. Burt, B. C. Portman, and L. D. Ferrell, Eds., pp. 147–198, Churchill Levingstone, New York, NY, USA, 5th edition, 2006. View at Google Scholar
  37. G. U. Denk, H. Bikker, R. H. L. dit Deprez et al., “ABCB4 deficiency: a family saga of early onset cholelithiasis, sclerosing cholangitis and cirrhosis and a novel mutation in the ABCB4 gene,” Hepatology Research, vol. 40, no. 9, pp. 937–941, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Erlinger, “Drug-induced cholestasis,” Journal of Hepatology, vol. 26, no. 1, supplement, pp. 1–4, 1997. View at Google Scholar · View at Scopus